看板 medstudent 關於我們 聯絡資訊
Title Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial Origin: The Lancet Oncology, Volume 13, Issue 5, Pages 528 - 538, May 2012 Author: Prof Vincent A Miller MD 拜求 paper 一篇 若有請寄到我的信箱 : skimylin@gmail.com -- -- ※ 發信站: 批踢踢實業坊(ptt.cc) ◆ From: 140.128.153.200
stillcat:sent! 05/09 15:59